Visit us at booth #813.
Sign-up for the 3C Patch Dine & Demo Event.
PERSONALIZED WOUND HEALING
EVERY WOUND IS PERSONAL
Reapplix has established that every patient holds the key to their own successful wound treatment. Using just a small sample of the patient’s blood – nothing else – the 3C Patch® System separates, coagulates and compacts the blood components into a solid patch.
EVERY PATIENT HOLDS A KEY TO THEIR OWN WOUND HEALING
3C Patch® is an autologous product, meaning it is made from the patient`s own blood. No additives are needed to create a robust autologous leukocyte and platelet rich fibrin patch1, at the point of care, to place directly onto non-healing wounds such as diabetic foot ulcers, leg ulcers and mechanically or surgically debrided wounds.
3C PATCH® IS EVIDENCE BASED AND IWGDF RECOMMENDED
The International Working Group on the Diabetic Foot (IWGDF) now recommends the use of Reapplix’s technology, the 3C Patch®, an autologous combined leucocyte, platelet and fibrin, as an adjunctive treatment.
PUBLICATION IN THE LANCET DIABETES & ENDOCRINOLOGY
The positive outcome data of an independent Randomized Controlled Trial (RCT) of 3C Patch® was published in The Lancet Diabetes & Endocrinolocy on September 19, 20181. The results have also been presented at many scientific meetings in USA and Europe including the American Diabetes Association 78th Scientific Sessions meeting, June 2018, the Diabetic Foot Study Group Conference September 2018, and at the annual meeting of the European Association for the Study of Diabetes (EASD), October 2018.
TRULY AUTOLOGOUS WITH NO REAGENTS OR ADDITIVES
3C PATCH® SYSTEM
The 3C Patch® System contains rigorously designed and patented components. The unique process provides autologous wound management at the point of care, meaning a 100% unique patch prepared from the patient’s own blood:
PERFORMANCE AND DESIGN
The 3CP® Centrifuge and the 3C Patch® Device work together as a System. The sterile 3C Patch® Device is a precision engineered mini cell processor working together with the specially designed centrifuge that drives the patented 3C Patch® System to form the autologous leukocyte and platelet rich fibrin patch from an 18 ml. blood sample.1
Centrifuge process steps significantly influence the outcome of blood derived products. The 3CP® Centrifuge automatically drives the proprietary process ensuring consistency and saving valuable clinician time.
THE 3C PATCH® KIT
The 3C Patch® Kit is a procedure pack providing the single-use components needed for the production of the 3C Patch®
Each 3C Patch® Kit is packed in an individual box and contains all the components needed to produce a 3C Patch®.
The only missing ingredient is an 18 ml sample of the patient’s own blood which is taken at the point of care.
- 1 x 3C Patch® Device
- 1 x 3C Patch® Needle Holder
- 1 x 3C Patch® Winged blood sampling set with protector
- 1 x 3C Patch® Primary cover dressing
- 1 x 3C Patch® Alcohol swab (for disinfection of the skin before needle insertion)
- 1x Post blood sample adhesive bandage
The 3C Patch® System is cleared by the FDA for the management of exuding wounds, such as leg ulcers, pressure ulcers, diabetic ulcers, and mechanically or surgically debrided wounds.
CE MARKED IN EUROPE
The intended use of the 3C Patch® Device is to produce an autologous platelet-rich fibrin for wound management of recalcitrant wounds.
Philip Herbert, 54 years old
Dr. Bo Jørgensen
Copenhagen Wound Healing Center, DK
Photo: Claus Peuckert
Lisbeth Vorbeck, Nurse
Copenhagen Wound Healing Center, DK